Abstract:The National Institutes of Health leveled new focus on sex as a biological variable with the goal of understanding sex-specific differences in health and physiology. We previously published a functional assessment of the impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology (Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu J, Sandhu S, Mueller B, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM. Am J Physiol Renal Physiol 317: F996–F1009, 2019). Here, we meas… Show more
“…Then, the mice were administered drugs by intravesical instillation once a week for a total of four times, during which the mice urinated normally since the diameter of urethras of mice (≈2 mm) was greater than the diameter of BSA 20 ‐MBs. [ 27 ] To visually monitor the progress of bladder tumors, noninvasive ultrasound imaging was used to image the tumors throughout the whole treatment process. As shown in Figure 6b, there was a hyperechoic signal in the bladder at day 0, indicating that the orthotopic tumors were successfully constructed, in which the size of tumors could not be identical because of the individual differences between mice.…”
Intravesical instillation is an effective treatment for bladder cancer. However, clinical anticancer agents always suffer rapid excretion by periodic urination, leading to low therapeutic efficacy. Prolonging the retention time of drugs in the bladder is the key challenge for intravesical instillation treatment. Herein, a facile and powerful surface cross‐linking‐freeze drying strategy is proposed to generate ultra‐stable albumin bovine air microbubbles (BSA‐MBs) that can float and adhere to the bladder wall to overcome the excretion of urination and exhibit a remarkable property of long‐term retention in the bladder. More noteworthy, BSA‐MBs are endowed with a specific three‐layer structure, namely, the outer membrane, middle drug loading layer and inner air core, which makes them have a low density to easily float and possess a high drug loading capacity. Based on their unique superiorities, the therapeutic potential of doxorubicin (DOX)‐loaded BSA‐MBs (DOX‐MBs) is exemplified by intravesical instillation for bladder cancer. After injection into the bladder, DOX‐MBs can remain in the bladder for a long time and sustain the release of DOX in urine, exhibiting potent anticancer efficacy. Consequently, the prolonged retention of BSA‐MBs in the bladder renders them as an effective floating drug delivery system for intravesical instillation therapy.
“…Then, the mice were administered drugs by intravesical instillation once a week for a total of four times, during which the mice urinated normally since the diameter of urethras of mice (≈2 mm) was greater than the diameter of BSA 20 ‐MBs. [ 27 ] To visually monitor the progress of bladder tumors, noninvasive ultrasound imaging was used to image the tumors throughout the whole treatment process. As shown in Figure 6b, there was a hyperechoic signal in the bladder at day 0, indicating that the orthotopic tumors were successfully constructed, in which the size of tumors could not be identical because of the individual differences between mice.…”
Intravesical instillation is an effective treatment for bladder cancer. However, clinical anticancer agents always suffer rapid excretion by periodic urination, leading to low therapeutic efficacy. Prolonging the retention time of drugs in the bladder is the key challenge for intravesical instillation treatment. Herein, a facile and powerful surface cross‐linking‐freeze drying strategy is proposed to generate ultra‐stable albumin bovine air microbubbles (BSA‐MBs) that can float and adhere to the bladder wall to overcome the excretion of urination and exhibit a remarkable property of long‐term retention in the bladder. More noteworthy, BSA‐MBs are endowed with a specific three‐layer structure, namely, the outer membrane, middle drug loading layer and inner air core, which makes them have a low density to easily float and possess a high drug loading capacity. Based on their unique superiorities, the therapeutic potential of doxorubicin (DOX)‐loaded BSA‐MBs (DOX‐MBs) is exemplified by intravesical instillation for bladder cancer. After injection into the bladder, DOX‐MBs can remain in the bladder for a long time and sustain the release of DOX in urine, exhibiting potent anticancer efficacy. Consequently, the prolonged retention of BSA‐MBs in the bladder renders them as an effective floating drug delivery system for intravesical instillation therapy.
“…The majority of previous basic research investigations on the mechanisms of LUTD after spinal cord injury (SCI) were predominantly performed using female rodents 3–5 . In addition, there have been no studies of bladder and urethral coordination in male mice although several researchers have suggested that there are sex differences in the urethra, in terms of its function, morphology, and distribution of receptors such as α1‐adrenoceptors and hormonal receptors 6–8 . It has been shown that male and female rats exhibit bursting activity of the external urethral sphincter (EUS) during voiding, which acts as urethral pumping function to help efficient voiding 9–11 .…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5] In addition, there have been no studies of bladder and urethral coordination in male mice although several researchers have suggested that there are sex differences in the urethra, in terms of its function, morphology, and distribution of receptors such as α1adrenoceptors and hormonal receptors. [6][7][8] It has been shown that male and female rats exhibit bursting activity of the external urethral sphincter (EUS) during voiding, which acts as urethral pumping function to help efficient voiding. [9][10][11] In contrast, in humans 12 and in female mice, EUS relaxes during voiding, so that voiding occurs during EUSelectromyography (EMG) silent periods in both spinal intact (SI) and SCI conditions, 10 although it is not well clarified whether EUS bursting activity is involved in efficient voiding in male mice.…”
ObjectivesWe examined sex differences of lower urinary tract function and molecular mechanisms in mice with and without spinal cord injury (SCI).MethodsSCI was induced by Th8−9 spinal cord transection in male and female mice. We evaluated cystometrograms (CMG) and electromyography (EMG) of external urethral sphincter (EUS) at 6 weeks after SCI in spinal intact (SI) and SCI mice. The mRNA levels of Piezo2 and TRPV1 were measured in L6‐S1 dorsal root ganglia (DRG). Protein levels of nerve growth factor (NGF) in the bladder mucosa was evaluated using an enzyme‐linked immunosorbent assay.ResultsSex differences were found in the EUS behavior during voiding as voiding events in female mice with or without SCI occurred during EUS relaxation periods without EUS bursting activity whereas male mice with or without SCI urinated during EUS bursting activity in EMG recordings. In both sexes, SCI decreased voiding efficiency along with increased tonic EUS activities evident as reduced EUS relaxation time in females and longer active periods of EUS bursting activity in males. mRNA levels of Piezo2 and TRPV1 of DRG in male and female SCI mice were significantly upregulated compared with SI mice. NGF in the bladder mucosa showed a significant increase in male and female SCI mice compared with SI mice. However, there were no significant differences in Piezo2 or TRPV1 levels in DRG or NGF protein levels in the bladder mucosa between male and female SCI mice.ConclusionsWe demonstrated that female and male mice voided during EUS relaxation and EUS bursting activity, respectively. Also, upregulation of TRPV1 and Piezo2 in L6‐S1 DRG and NGF in the bladder could be involved in SCI‐induced lower urinary tract dysfunction in both sexes of mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.